Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesClinical outcome of immunoglobulin light chain amyloidosis affecting the kidney
Nephrology Dialysis Transplantation, 05/06/09
Gertz MA et al. - Data suggest that presenting 24-h urine protein loss and creatinine values may predict which patients presented with immunoglobulin light chain amyloidosis (AL) will require dialysis. Median survival for pts starting dialysis is <1 year; presence of λ light chain amyloid predicts the increased likelihood of renal involvement.
Methods- Study to investigate the long-term predictors for and outcomes after renal replacement therapy in pts with AL
- Kaplan–Meier and multivariate analyses performed in a uniformly treated cohort of 145 pts monitored for 11 yrs
- Outcome measurements were needed for renal replacement therapy and survival
- Among pts presenting with renal AL, 42% received renal replacement therapy vs 5% pts w/o
- Pts with renal amyloid who received dialysis support had higher serum creatinine and 24-h urine protein levels
- Pts with λ light chain amyloid had more renal involvement and had greater urinary protein loss vs pts with κ light chain amyloid
- Serum creatinine level was an independent predictor of overall survival when corrected for cardiac involvement
- For 38 pts who received dialysis, median survival from day 1 of dialysis was 10.4 mo
- 26% of patients with AL ultimately received renal replacement therapy vs 42% of patients who presented with renal AL specifically
Related Articles
Prevention of Amyloidosis in Familial Mediterranean Fever with Colchicine: A Case-Control Study in Armenia
Medical Principles and Practice, 10/05/09
Relevance Score: 94%
Unusual Combination of Tracheobronchopathia Osteochondroplastica and AA Amyloidosis
Yonsei Medical Journal, 10/29/09
Relevance Score: 89%
A case with rheumatoid arthritis and systemic reactive AA amyloidosis showing rapid regression of amyloid deposition on gastroduodenal mucosa after a combined therapy of corticosteroid and etanercept
Rheumatology International, 10/16/09
Relevance Score: 89%
Vitreous Amyloidosis in Two Sisters as the Indication of Transthyretin-Related Familial Form of Systemic Amyloidosis Among Liver Transplantation Candidates
Transplantation Proceedings, 11/12/09
Relevance Score: 87%
Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis
Scandinavian Journal of Rheumatology, 10/02/09
Relevance Score: 87%
Today in Amyloidosis...keeping you current
Receive free subspecialty "5-minute updates" via email
MEFV mutations in Egyptian patients suffering from familial Mediterranean fever: analysis of 12 gene mutations
Rheumatology International, 10/16/09
Classification of amyloidosis by laser microdissection and mass spectrometry based proteomic analysis in clinical biopsy specimens
Blood, 10/09/09
Prevention of Amyloidosis in Familial Mediterranean Fever with Colchicine: A Case-Control Study in Armenia
Medical Principles and Practice, 10/05/09
Sponsor
Article Search
Sponsor